<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04719247</url>
  </required_header>
  <id_info>
    <org_study_id>PED19-3D</org_study_id>
    <nct_id>NCT04719247</nct_id>
  </id_info>
  <brief_title>Clinical and Radiographic Evaluation of Turmeric, Thymus Vulgaris, Nigella Sativa and Aloe Vera as Pulpotomy Medicaments in Primary Teeth</brief_title>
  <acronym>RCT</acronym>
  <official_title>Clinical and Radiographic Evaluation of Turmeric, Thymus Vulgaris, Nigella Sativa and Aloe Vera as Pulpotomy Medicaments in Primary Teeth&quot; A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      when caries reaches the pulp of the tooth, it has to be removed and replaced with a material.&#xD;
      In this study im examining the clinical and radiographic signs and symptoms after using&#xD;
      different natural materials in pulpotomized molars and compared to the formocresol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who have irreversible pulpitis and need pulpotomy will be selected randomly from the&#xD;
      out patient clinic. they will be assigned randomly to different study and control groups.&#xD;
      pulpotomy will be performed in the second primary molar and 1 of the five materials will be&#xD;
      put in the pulp chamber (aloe vera, nigella sativa, thymus vulgaris, turmeric and&#xD;
      formocresol). It will be covered with a restoration and a stainless steel crown. Patients&#xD;
      follow up will be done after 1,3,6 and 12 months to assess clinical and radiographic signs&#xD;
      and symptoms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical signs and symptoms of pulp reaction</measure>
    <time_frame>1to 6 months</time_frame>
    <description>Evaluated using Zurn and Seale criteria. (pain, infection, gingival health, tooth mobility)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic signs of pulp reaction</measure>
    <time_frame>1 to 6 months</time_frame>
    <description>evaluated using Zurn and Seale criteria. (radiolucency, bone resorption, internal or external resorption)</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pulpitis - Irreversible</condition>
  <arm_group>
    <arm_group_label>Turmeric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Turmeric extract will be used as a dental pulp dressing material after pulpotomy and compared with Formocresol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thymus Vulgaris</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Thymus Vulgaris extract will be used as a dental pulp dressing material after pulpotomy and compared with Formocresol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nigella Sativa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nigella Sativa extract will be used as a dental pulp dressing material after pulpotomy and compared with Formocresol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aloe Vera</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aloe Vera extract will be used as a dental pulp dressing material after pulpotomy and compared with Formocresol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Formocresol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Formocresol will be used as a dental pulp dressing material after pulpotomy to be compared with other materials.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulpotomy</intervention_name>
    <description>Irreversibly damaged dental pulp is partially removed and a dressing either Turmeric or Thymus Vulgaris or Nigella Sativa or Aloe Vera is placed. Clinical and Radiographic signs and symptoms are assessed and compared with Formocresol.</description>
    <arm_group_label>Aloe Vera</arm_group_label>
    <arm_group_label>Formocresol</arm_group_label>
    <arm_group_label>Nigella Sativa</arm_group_label>
    <arm_group_label>Thymus Vulgaris</arm_group_label>
    <arm_group_label>Turmeric</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged from 4 to 7 years old&#xD;
&#xD;
          -  Patients who are medically free&#xD;
&#xD;
          -  Patients who have a restorable vital deep carious primary molar which is indicated for&#xD;
             pulpotomy.&#xD;
&#xD;
          -  No clinical signs or symptoms as pain on percussion, tooth mobility, presence of sinus&#xD;
             or fistula, history of swelling.&#xD;
&#xD;
          -  No radiographic signs of any periapical pathosis or signs of internal or external root&#xD;
             resorption.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who have any medical condition.&#xD;
&#xD;
          -  Teeth that are badly broken down, that cannot be restored.&#xD;
&#xD;
          -  Presence of uncontrolled bleeding.&#xD;
&#xD;
          -  Clinical evidence of non-vitality such as presence of an abscess or a sinus or&#xD;
             premature mobility.&#xD;
&#xD;
          -  Radiographic evidence of bone resorption, internal or external root resorption and&#xD;
             periapical or interradicular radiolucency.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Noha S Kabil, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Basma G Awad, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Lecturer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rana M Sharaf, Masters</last_name>
    <phone>00201007777326</phone>
    <email>ranasharaf@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Dentistry, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Basma G Awad, PHD</last_name>
      <phone>00201001782744</phone>
      <email>basmagamal@dent.asu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Saikiran KV, Kamatham R, Sahiti PS, Nuvvula S. Pulpotomy medicaments in primary teeth: A literature reviewof natural alternatives. SRM J Res Dent Sci 2018; 9:181-5.</citation>
  </reference>
  <reference>
    <citation>Kumar Praveen NH, Nayak Rashmi, Bhaskar Vipin K, Mopkar Pujan P Pulpotomy Medicaments: Continued Search for New Alternatives- A Review. 2014; OHDM - Vol. 13 - No. 4</citation>
  </reference>
  <reference>
    <citation>Al-Dlaigan YH. Pulpotomy Medicaments used in Deciduous Dentition: An Update. J Contemp Dent Pract. 2015 Jun 1;16(6):486-503. Review.</citation>
    <PMID>26323453</PMID>
  </reference>
  <reference>
    <citation>Salman BN, Vahabi S, Rad MM. Use of herbs and medicinal plants in dentistry: a review. Journal Dental School 2017; 35, No. 2: 58-64</citation>
  </reference>
  <reference>
    <citation>Subramanyam D, Somasundaram S. Clinical and Radiographic Outcome of Herbal Medicine Versus Standard Pulpotomy Medicaments in Primary Molars: A Systematic Review. Journal of Clinical and Diagnostic Research 2017 Oct; 11(10): ZE12-ZE16</citation>
  </reference>
  <reference>
    <citation>Kumar G, Jalaluddin M, Rout P, Mohanty R, Dileep CL. Emerging trends of herbal care in dentistry. J Clin Diagn Res. 2013 Aug;7(8):1827-9. doi: 10.7860/JCDR/2013/6339.3282. Epub 2013 Aug 1.</citation>
    <PMID>24086929</PMID>
  </reference>
  <reference>
    <citation>Kuwatada JS, Raja M, Sood P. Turmeric: A Boon to Oral Health. Int J Oral Care Res 2017;5(4):338-341.</citation>
  </reference>
  <reference>
    <citation>Srivastava R, Jyoti B, Pathak S, Wazir S, Shukla A, Sajid MdZ Aloe Vera: The Herbal Magic Wand. J Clin Den Res Edu 2014; 3 (8).</citation>
  </reference>
  <reference>
    <citation>Huth KC, Paschos E, Hajek-Al-Khatar N, Hollweck R, Crispin A, Hickel R, Folwaczny M. Effectiveness of 4 pulpotomy techniques--randomized controlled trial. J Dent Res. 2005 Dec;84(12):1144-8.</citation>
    <PMID>16304444</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 9, 2020</study_first_submitted>
  <study_first_submitted_qc>January 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>January 17, 2021</last_update_submitted>
  <last_update_submitted_qc>January 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Rana sharaf</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>all collected IPD, all IPD that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>starting 6 months after publication</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

